Takeda Pharmaceutical Profit Margin 2007-2019 | TAK

Current and historical gross margin, operating margin and net profit margin for Takeda Pharmaceutical (TAK) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Takeda Pharmaceutical net profit margin as of June 30, 2019 is 4.01%.
Takeda Pharmaceutical Annual Profit Margins
Takeda Pharmaceutical Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $27.154B $18.875B
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda's core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide acetate for the treatment of prostate cancer and endometriosis, pioglitazone hydrocholoride for the treatment of diabetes, and candesartan cilexetil for the treatment of hypertension. The Company promotes enhancing R&D pipeline, while concentrating its management resources to the four core therapeutic areas: lifestyle-related diseases, oncology and urological diseases, central nervous system disease and gastroenterological diseases. It operates in two segments- Ethical drug business and Consumer healthcare business. Consumer healthcare business provides Alinamin (vitamin B1 derivative preparations, etc.), Benza (cold remedies). Takeda Pharmaceutical Company Limited is headquartered in Osaka, Japan.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $57.794B 35.59
Astellas Pharma (ALPMY) Japan $28.552B 14.00
Eisai (ESALY) Japan $14.621B 25.14
UCB SA (UCBJF) Belgium $14.267B 0.00
Merck (MKGAF) Germany $14.113B 19.26
Grifols, S.A (GRFS) Spain $13.964B 17.82
Ono Pharmaceutical (OPHLF) Japan $9.383B 20.06
Ionis Pharmaceuticals (IONS) United States $9.301B 20.06
Neurocrine Biosciences (NBIX) United States $8.829B 0.00
IPSEN SA ADR (IPSEY) France $8.399B 0.00
Sage Therapeutics (SAGE) United States $8.254B 0.00
Catalent (CTLT) United States $7.498B 29.68
Jazz Pharmaceuticals (JAZZ) Ireland $7.441B 9.79
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.781B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $5.025B 18.07
FibroGen (FGEN) United States $3.606B 90.20
United Therapeutics (UTHR) United States $3.538B 0.00
Nektar Therapeutics (NKTR) United States $3.525B 0.00
Evotec AG (EVTCY) Germany $3.369B 46.12
Taro Pharmaceutical Industries (TARO) Israel $3.144B 11.27
Tilray (TLRY) Canada $3.090B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.840B 65.11
PTC Therapeutics (PTCT) United States $2.527B 0.00
Portola Pharmaceuticals (PTLA) United States $2.096B 0.00
Xencor (XNCR) United States $2.003B 43.68
Zogenix (ZGNX) United States $1.842B 0.00
Heron Therapeutics (HRTX) United States $1.637B 0.00
USANA Health Sciences (USNA) United States $1.596B 16.01
Pacira Pharmaceuticals (PCRX) United States $1.588B 57.80
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
Corcept Therapeutics (CORT) United States $1.517B 20.84
Ironwood Pharmaceuticals (IRWD) United States $1.502B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.338B 22.07
Radius Health (RDUS) United States $1.307B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.299B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.044B 4.65
Aerie Pharmaceuticals (AERI) United States $1.015B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.000B 0.00
ArQule (ARQL) United States $0.958B 0.00
Endo (ENDP) Ireland $0.878B 1.55
TherapeuticsMD (TXMD) United States $0.825B 0.00
Concordia (CXRXF) Canada $0.770B 0.00
Karyopharm Therapeutics (KPTI) United States $0.683B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.640B 0.00
Akebia Therapeutics (AKBA) United States $0.606B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.605B 0.00
Organogenesis Holdings (ORGO) United States $0.569B 0.00
Lannett Co Inc (LCI) United States $0.564B 5.94
Translate Bio (TBIO) United States $0.540B 0.00
Flexion Therapeutics (FLXN) United States $0.533B 0.00
Dermira (DERM) United States $0.487B 0.00
Indivior (INVVY) United States $0.482B 1.74
Aptorum Group (APM) China $0.477B 0.00
ImmunoGen (IMGN) United States $0.475B 0.00
Siga Technologies (SIGA) United States $0.462B 1.08
Dova Pharmaceuticals (DOVA) United States $0.461B 0.00
Innate Pharma SA (IPHYF) France $0.444B 0.00
ChemoCentryx (CCXI) United States $0.440B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.427B 19.43
Crinetics Pharmaceuticals (CRNX) United States $0.413B 0.00
Harpoon Therapeutics (HARP) United States $0.400B 0.00
Collegium Pharmaceutical (COLL) United States $0.400B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.371B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.340B 0.00
DURECT (DRRX) United States $0.336B 0.00
Ardelyx (ARDX) United States $0.333B 0.00
CV Sciences (CVSI) United States $0.310B 0.00
OptiNose (OPTN) United States $0.298B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.296B 0.00
Xeris Pharmaceuticals (XERS) United States $0.281B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.277B 0.00
KalVista Pharmaceuticals (KALV) United States $0.272B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.269B 0.00
Recro Pharma (REPH) United States $0.269B 0.00
Concert Pharmaceuticals (CNCE) United States $0.255B 0.00
Molecular Templates (MTEM) United States $0.232B 0.00
CannTrust Holdings (CTST) Canada $0.228B 0.00
Calithera Biosciences (CALA) United States $0.225B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.214B 0.00
Ocular Therapeutix (OCUL) United States $0.210B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.203B 0.00
GlycoMimetics (GLYC) United States $0.200B 0.00
Nature's Sunshine Products (NATR) United States $0.193B 32.29
Redhill Biopharma (RDHL) Israel $0.168B 0.00
Generex Biotechnology (GNBT) United States $0.167B 0.00
Taiwan Liposome (TLC) Taiwan $0.159B 0.00
IMV INC (IMV) Canada $0.156B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.147B 0.00
MEI Pharma (MEIP) United States $0.143B 0.00
Cardiome Pharma (CORV) Canada $0.139B 0.00
Majesco Entertainment (PTE) United States $0.118B 0.00
Jounce Therapeutics (JNCE) United States $0.116B 0.00
ElectroCore (ECOR) United States $0.111B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.110B 0.00
Mast Therapeutics (SVRA) United States $0.109B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Genocea Biosciences (GNCA) United States $0.094B 0.00
Neos Therapeutics (NEOS) United States $0.093B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.088B 0.00
Iterum Therapeutics (ITRM) Ireland $0.087B 0.00
MediWound (MDWD) Israel $0.087B 0.00
Aquestive Therapeutics (AQST) United States $0.085B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.081B 0.00
RENEURON GP (RNUGF) United Kingdom $0.079B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.078B 29.82
Entasis Therapeutics Holdings (ETTX) United States $0.076B 0.00
Natural Alternatives (NAII) United States $0.075B 7.48
Lipocine (LPCN) United States $0.074B 0.00
Novan (NOVN) United States $0.072B 0.00
Nivalis Therapeutics (ALPN) United States $0.071B 0.00
Champions Oncology (CSBR) United States $0.070B 605.00
Infinity Pharmaceuticals (INFI) United States $0.070B 0.00
Otonomy (OTIC) United States $0.066B 0.00
Jaguar Animal Health (JAGX) United States $0.062B 0.00
SCYNEXIS (SCYX) United States $0.061B 0.00
China SXT Pharmaceuticals (SXTC) China $0.061B 0.00
Capnia (SLNO) United States $0.060B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.058B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.055B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.052B 0.00
CTI BioPharma (CTIC) United States $0.050B 0.00
Forward Pharma (FWP) Denmark $0.047B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.047B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.045B 1.56
Aclaris Therapeutics (ACRS) United States $0.043B 0.00
Melinta Therapeutics (MLNT) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.039B 0.00
PharmAthene (ALT) United States $0.035B 0.00
Bio-Path Holdings (BPTH) United States $0.034B 0.00
Opexa Therapeutics (ACER) United States $0.033B 0.00
Biomerica (BMRA) United States $0.030B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.020B 0.00
Heat Biologics (HTBX) United States $0.019B 0.00
Achieve Life Sciences (ACHV) United States $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.018B 0.00
HANCOCK JAFFE (HJLI) United States $0.017B 0.00
Onconova Therapeutics (ONTX) United States $0.015B 0.00
Vical (BBI) United States $0.015B 0.00
Shineco (TYHT) China $0.015B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.013B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
VAXART, INC (VXRT) United States $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Flex Pharma (SLRX) United States $0.005B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00